MoonLake Clears A Key Regulatory Hurdle, And Shares Rocket
Shares of MoonLake Immunotherapeutics bounded higher Monday after the biotech said it met with the Food and Drug Administration in April.
Open original sourceLoading market dashboard
Shares of MoonLake Immunotherapeutics bounded higher Monday after the biotech said it met with the Food and Drug Administration in April.
Open original source